
    
      The aim of this study is to assess the efficacy and safety of paroxetine, an antidepressant
      agent, in the prevention of depression induced by PEG-interferon given for the treatment of
      chronic hepatitis C. This is a comparative study including two groups of patients randomly
      allocated : one with paroxetine and the other with the placebo. The rate of depression will
      be compared between the 2 groups
    
  